{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:16:38Z","timestamp":1787238998588,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Mol Allergy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Allergic rhinitis (AR) is very commonly caused by pollens. The symptoms of AR consist of sneezing, nasal congestion, rhinorrhea, nasal itching and airflow obstruction. The diagnosis has long been based on clinical history, skin prick tests and in vitro measurement of specific IgE, but the innovative approach of precision medicine has made diagnostic tools of much greater accuracy available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas covered<\/jats:title>\n                    <jats:p>This review covers the advances in the treatment of seasonal AR concerning the drugs to be used according to the grade of disease and the characteristics of the patients, and the role of allergen immunotherapy (AIT), which is the only treatment capable of acting, in addition to the symptoms, on the cause of AR and therefore to modify its natural history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Expert opinion<\/jats:title>\n                    <jats:p>Drug treatment of AR include a large number of agents, the choice of which depends on the severity of the disease. AIT has high evidence of efficacy demonstrated by meta-analyses, and further improvement is currently apparent, as for diagnosis, applying the means of precision medicine. However, when AIT is performed in current practice, without the strict rules of controlled trials, long-term low adherence is a major problem to be solved.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12948-022-00176-x","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T09:03:50Z","timestamp":1660122230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current treatment strategies for seasonal allergic rhinitis: where are we heading?"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-7902","authenticated-orcid":false,"given":"Erminia","family":"Ridolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoforo","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pucciarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Makri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"4","key":"176_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaci.2020.01.006","volume":"145","author":"M Westman","year":"2020","unstructured":"Westman M, \u00c5berg K, Apostolovic D, et al. Mechanisms for the Development of Allergies (MeDALL) consortium. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J Allergy Clin Immunol. 2020;145(4):1174\u201381.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"176_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMcp1412282","volume":"372","author":"LM Wheatley","year":"2015","unstructured":"Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N Engl J Med. 2015;372(5):456\u201363.","journal-title":"N Engl J Med"},{"issue":"1","key":"176_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599814561600","volume":"152","author":"MD Seidman","year":"2015","unstructured":"Seidman MD, Richard K, Gurgel RK, et al. Clinical practice guideline: Allergic rhinitis. Guideline Otolaryngology Development Group. AAO-HNSF. Otolaryngol Head Neck Surg. 2015;152(1):S1-43.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"176_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1067\/mai.2002.121701","volume":"109","author":"S Guerra","year":"2002","unstructured":"Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419\u201325.","journal-title":"J Allergy Clin Immunol"},{"key":"176_CR5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","volume":"372","author":"R Shaaban","year":"2008","unstructured":"Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal populationbased study. Lancet. 2008;372:1049\u201357.","journal-title":"Lancet"},{"issue":"5","key":"176_CR6","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1067\/mai.2001.118891","volume":"108","author":"J Bousquet","year":"2001","unstructured":"Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and Its impact on asthma. J Allergy Clin Immunol. 2001;108(5):S147-334.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"176_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/all.14575","volume":"76","author":"C Incorvaia","year":"2021","unstructured":"Incorvaia C, Al-Ahmad M, Ansotegui IJ, et al. Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model. Allergy. 2021;76(4):1041\u201352.","journal-title":"Allergy"},{"key":"176_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12948-015-0029-5","volume":"13","author":"GV Canonica","year":"2015","unstructured":"Canonica GV, Triggiani M, Senna GE. 360-degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;13:25.","journal-title":"Clin Mol Allergy"},{"key":"176_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/pharmacy8020085","volume":"8","author":"O Louren\u00e7o","year":"2020","unstructured":"Louren\u00e7o O, Bosnic-Anticevich S, Costa E, et al. Managing allergic rhinitis in the pharmacy: An ARIA guide for implementation in practice. Pharmacy. 2020;8:85.","journal-title":"Pharmacy"},{"key":"176_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.12.002","author":"EO Meltzer","year":"2016","unstructured":"Meltzer EO. Allergic Rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am. 2016. https:\/\/doi.org\/10.1016\/j.iac.2015.12.002.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"25","key":"176_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pai.13189","volume":"31","author":"M Alvaro-Lozano","year":"2020","unstructured":"Alvaro-Lozano M, Akdis CA, Akdis M, et al. EAACI allergen immunotherapy user\u2019s guide. Pediatr Allergy Immunol. 2020;31(25):1\u2013101.","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"176_CR12","first-page":"108","volume":"8","author":"SK Wise","year":"2018","unstructured":"Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108\u2013352.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"11","key":"176_CR13","doi-asserted-by":"publisher","first-page":"e0207290","DOI":"10.1371\/journal.pone.0207290","volume":"13","author":"D Caimmi","year":"2018","unstructured":"Caimmi D, Baiz N, Sanyal S, et al. Discriminating severe seasonal allergic rhinitis. Results from a large nation-wide database. PLoS ONE. 2018;13(11):e0207290.","journal-title":"PLoS ONE"},{"issue":"4","key":"176_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMp1006304","volume":"363","author":"MA Hamburg","year":"2010","unstructured":"Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363(4):301\u20134.","journal-title":"N Engl J Med"},{"issue":"3","key":"176_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2500\/aap.2010.31.3342","volume":"31","author":"RG Slavin","year":"2010","unstructured":"Slavin RG. Special considerations in treatment of allergic rhinitis in the elderly: role of intranasal corticosteroids. Allergy Asthma Proc. 2010;31(3):179\u201384.","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"176_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/all.12181","volume":"68","author":"U Berger","year":"2013","unstructured":"Berger U, Karatzas K, Jaeger S, et al. Personalized pollen-related symptom-forecast information services for allergic rhinitis patients in Europe. Allergy. 2013;68(8):963\u20135.","journal-title":"Allergy"},{"issue":"6","key":"176_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10517-019-04437-9","volume":"166","author":"IV Bogdanov","year":"2019","unstructured":"Bogdanov IV, Finkina EI, Melnikova DN, et al. Analysis of the serum cytokine profile in allergic patients opens a way to personalized treatment of allergy. Bull Exp Biol Med. 2019;166(6):770\u20133.","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"176_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cea.13264","volume":"49","author":"M Di Fraia","year":"2019","unstructured":"Di Fraia M, Arasi S, Castelli S, et al. A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study. Clin Exp Allergy. 2019;49(3):341\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"176_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13052-020-00870-z","volume":"46","author":"S Tripodi","year":"2020","unstructured":"Tripodi S, Giannone A, Sfika I, et al. Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians. Ital J Pediatr. 2020;46(1):105.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"176_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40413-015-0079-7","volume":"8","author":"GW Canonica","year":"2015","unstructured":"Canonica GW, Bachert C, Hellings P, et al. Allergen immunotherapy (AIT): a prototype of precision medicine. World Allergy Organ J. 2015;8(1):31.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"176_CR21","first-page":"CD001936","volume":"2017","author":"MA Calderon","year":"2007","unstructured":"Calderon MA, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007;2007(1):CD001936.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"176_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaci.2011.03.049","volume":"128","author":"PM Matricardi","year":"2011","unstructured":"Matricardi PM, Kuna P, Panetta V, et al. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011;128(4):791\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"176_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.08.012","author":"D Di Bona","year":"2012","unstructured":"Di Bona D, Plaia A, Leto-Barone MS, et al. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. J Allergy Clin Immunol. 2012. https:\/\/doi.org\/10.1016\/j.jaci.2012.08.012.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"176_CR24","first-page":"71","volume":"1","author":"P Demoly","year":"2014","unstructured":"Demoly P, Calder\u00f3n MA, Devillier P, et al. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen induced seasonal allergic rhinoconjunctivitis. BMC Med. 2014;1(12):71.","journal-title":"BMC Med"},{"issue":"4","key":"176_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.alit.2015.05.008","volume":"64","author":"T Fujimura","year":"2015","unstructured":"Fujimura T, Kawamoto S. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Allergol Int. 2015;64(4):312\u201320.","journal-title":"Allergol Int"},{"key":"176_CR26","doi-asserted-by":"publisher","first-page":"5153184","DOI":"10.1155\/2016\/5153184","volume":"2016","author":"L Mattson","year":"2016","unstructured":"Mattson L, Lentini A, Gawel DR, et al. Potential involvement of type I interferon signaling in immunotherapy in seasonal allergic rhinitis. J Immunol Res. 2016;2016:5153184.","journal-title":"J Immunol Res"},{"key":"176_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.559746","volume":"11","author":"TT Ma","year":"2020","unstructured":"Ma TT, Cao MD, Yu RL, et al. Leukotriene A4 hydrolase is a candidate predictive biomarker for successful allergen immunotherapy. Front Immunol. 2020;11: 559746.","journal-title":"Front Immunol"},{"issue":"2","key":"176_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/all.13953","volume":"75","author":"PM Matricardi","year":"2020","unstructured":"Matricardi PM, Dramburg S, Alvarez-Perea A, et al. The role of mobile health technologies in allergy care: An EAACI position paper. Allergy. 2020;75(2):259\u201372.","journal-title":"Allergy"},{"issue":"3","key":"176_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jaci.2020.08.002","volume":"147","author":"M Mikus","year":"2021","unstructured":"Mikus M, Zandian A, Sj\u00f6berg R, et al. Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy. J Allergy Clin Immunol. 2021;147(3):1077\u201386.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"176_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/cea.13867","volume":"51","author":"S Arasi","year":"2021","unstructured":"Arasi S, Castelli S, Di Fraia M, et al. @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis. Clin Exp Allergy. 2021;51(6):821\u20138.","journal-title":"Clin Exp Allergy"},{"key":"176_CR31","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organisation; 2003."},{"issue":"4","key":"176_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-5151(03)00091-4","volume":"2","author":"S De Geest","year":"2003","unstructured":"De Geest S, Sabat\u00e8 E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323.","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"5","key":"176_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/all.12385","volume":"69","author":"M Makatsori","year":"2014","unstructured":"Makatsori M, Scadding GW, Lombardo C, et al. Dropouts in sublingual allergen immunotherapy trials - a systematic review. Allergy. 2014;69(5):571\u201380.","journal-title":"Allergy"},{"issue":"3","key":"176_CR34","first-page":"211","volume":"1","author":"EL Hannan","year":"2008","unstructured":"Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. Cardiovasc Interv. 2008;1(3):211\u20137.","journal-title":"Cardiovasc Interv"},{"issue":"3","key":"176_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jaci.2010.06.045","volume":"126","author":"G Senna","year":"2010","unstructured":"Senna G, Lombardi C, Canonica GW, et al. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers\u2019 viewpoint. J Allergy Clin Immunol. 2010;126(3):668\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"176_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","volume":"132","author":"MA Kiel","year":"2013","unstructured":"Kiel MA, R\u00f6der E, Gerth van Wijk R, et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132(2):353\u201360.","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"176_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2147\/PPA.S242957","volume":"13","author":"C Vogelberg","year":"2020","unstructured":"Vogelberg C, Br\u00fcggenj\u00fcrgen B, Richter H, et al. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma. Patient Prefer Adher. 2020;13(14):817\u201327.","journal-title":"Patient Prefer Adher"},{"issue":"6","key":"176_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/03007995.2018.1552044","volume":"35","author":"C Pitsios","year":"2019","unstructured":"Pitsios C, Dietis N. Ways to increase adherence to allergen immunotherapy. Curr Med Res Opin. 2019;35(6):1027\u201331.","journal-title":"Curr Med Res Opin"},{"key":"176_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)78276-6","author":"L Noon","year":"1911","unstructured":"Noon L, Cantab B. Prophylactic inoculation against hay fever. Lancet. 1911. https:\/\/doi.org\/10.1016\/S0140-6736(00)78276-6.","journal-title":"Lancet"},{"issue":"12","key":"176_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11882-016-0666-x","volume":"16","author":"G Passalacqua","year":"2016","unstructured":"Passalacqua G, Canonica GW, Bagnasco D. Benefit of SLIT and SCIT for allergic rhinitis and asthma. Curr Allergy Asthma Rep. 2016;16(12):88.","journal-title":"Curr Allergy Asthma Rep"},{"key":"176_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ctm2.1","volume":"10","author":"V Hox","year":"2020","unstructured":"Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl. 2020;10:1.","journal-title":"Clin Transl"},{"issue":"11","key":"176_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1185\/03007995.2013.822855","volume":"29","author":"E Compalati","year":"2013","unstructured":"Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin. 2013;29(11):1539\u201345.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"176_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36849\/JDD.2020.4835","volume":"19","author":"CW Lynde","year":"2020","unstructured":"Lynde CW, Sussman G, Dion PL, et al. Multidisciplinary real-world experience with bilastine, a second-generation antihistamine. Drugs Dermatol. 2020;19(2):145\u201354.","journal-title":"Drugs Dermatol"},{"issue":"6","key":"176_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4155\/tde.15.7","volume":"6","author":"E Ridolo","year":"2015","unstructured":"Ridolo E, Montagni M, Melli V, et al. A role for the intranasal formulation of azelastine hydrochloride\/fluticasone propionate in the treatment of allergic rhinitis. Ther Deliv. 2015;6(6):653\u20139.","journal-title":"Ther Deliv"},{"key":"176_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-07085-w","author":"R Chen","year":"2021","unstructured":"Chen R, Zheng D, Zhang Y, et al. Efficacy and safety of twice-daily olopatadine\u2013mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2021. https:\/\/doi.org\/10.1007\/s00405-021-07085-w.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"176_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","volume":"6","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95.","journal-title":"Nat Rev Dis Primers"},{"key":"176_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13223-020-00436-y","volume":"16","author":"L Hossenbaccus","year":"2020","unstructured":"Hossenbaccus L, Linton S, Garvey S, et al. Towards definitive management of allergic rhinitis: best use of new and established therapies. Allergy Asthma Clin Immunol. 2020;16:39.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"176_CR48","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/all.14582","volume":"75","author":"H Breiteneder","year":"2020","unstructured":"Breiteneder H, Peng YQ, Agache I, et al. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. 2020;75(12):3039\u201368.","journal-title":"Allergy"}],"container-title":["Clinical and Molecular Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12948-022-00176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12948-022-00176-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12948-022-00176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:08:40Z","timestamp":1668643720000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalmolecularallergy.biomedcentral.com\/articles\/10.1186\/s12948-022-00176-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1186\/s12948-022-00176-x","relation":{},"ISSN":["1476-7961"],"issn-type":[{"value":"1476-7961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}